202 related articles for article (PubMed ID: 38668434)
1. Impact of Equine Ocular Surface Squamous Neoplasia on Interactions between Ocular Transcriptome and Microbiome.
Chow L; Flaherty E; Pezzanite L; Williams M; Dow S; Wotman K
Vet Sci; 2024 Apr; 11(4):. PubMed ID: 38668434
[TBL] [Abstract][Full Text] [Related]
2. Novel ocular immunotherapy induces tumor regression in an equine model of ocular surface squamous neoplasia.
Wotman KL; Chow L; Martabano B; Pezzanite LM; Dow S
Cancer Immunol Immunother; 2023 May; 72(5):1185-1198. PubMed ID: 36367558
[TBL] [Abstract][Full Text] [Related]
3. Predictors of Ocular Surface Squamous Neoplasia and Conjunctival Squamous Cell Carcinoma among Ugandan Patients: A Hospital-based Study.
Lloyd HCM; Arunga S; Twinamasiko A; Frederick MA; Onyango J
Middle East Afr J Ophthalmol; 2018; 25(3-4):150-155. PubMed ID: 30765953
[TBL] [Abstract][Full Text] [Related]
4. Bilateral ocular surface squamous neoplasia: A study of 25 patients and review of literature.
Vempuluru VS; Pattnaik M; Ghose N; Kaliki S
Eur J Ophthalmol; 2022 Jan; 32(1):620-627. PubMed ID: 33818167
[TBL] [Abstract][Full Text] [Related]
5. Interferon Alfa 2b for Ocular Surface Squamous Neoplasia: Factors Influencing the Treatment Response.
Kaliki S; Bejjanki KM; Desai A; Mohamed A
Semin Ophthalmol; 2019; 34(7-8):465-472. PubMed ID: 31370766
[TBL] [Abstract][Full Text] [Related]
6. Ocular Surface Squamous Neoplasia With Coexistent Microbial Keratitis: Incidence, Risk Factors, Clinical Features, Microbiological Profile, and Treatment Outcome.
Kapoor AG; Vempuluru VS; Laghimshetty S; Roy A; Sharma S; Mishra DK; Mohamed A; Kaliki S
Cornea; 2022 Mar; 41(3):294-303. PubMed ID: 34294636
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and Medical Management of Ocular Surface Squamous Neoplasia.
Sayed-Ahmed IO; Palioura S; Galor A; Karp CL
Expert Rev Ophthalmol; 2017; 12(1):11-19. PubMed ID: 28184236
[TBL] [Abstract][Full Text] [Related]
8. Clinical and Pathologic Presentation of Primary Ocular Surface Tumors among Zambians.
Julius P; Siyumbwa SN; Moonga P; Maate F; Kaile T; Kang G; West JT; Wood C; Angeletti PC
Ocul Oncol Pathol; 2021 Mar; 7(2):108-120. PubMed ID: 33869164
[TBL] [Abstract][Full Text] [Related]
9. Role of Conjunctival Ultraviolet Autofluorescence in Ocular Surface Squamous Neoplasia.
Yadav S; Gupta N; Singh R; Patil M; Meel R; Vanathi M; Kashyap S; Tandon R
Ocul Oncol Pathol; 2020 Dec; 6(6):422-429. PubMed ID: 33447592
[TBL] [Abstract][Full Text] [Related]
10. Topical 5-fluorouracil 1% for moderate to extensive ocular surface squamous neoplasia in 73 consecutive patients: Primary versus secondary treatment.
Leventer I; Singh H; Pashaee B; Raimondo CD; Khakh CK; Martin JL; Acharya B; Zhang Q; Lally SE; Shields CL
Asia Pac J Ophthalmol (Phila); 2024; 13(2):100052. PubMed ID: 38521390
[TBL] [Abstract][Full Text] [Related]
11. Variable presentations of six conjunctival/limbal ocular surface squamous neoplasia (OSSN) cases: How good is our clinical judgment evidenced by the correlation to the histopathological findings and diagnosis?
Alharbi I; Alfawaz AM; Otaif W; Al-Dahmash SA; Alkatan HM
Int J Surg Case Rep; 2024 Mar; 116():109359. PubMed ID: 38330700
[TBL] [Abstract][Full Text] [Related]
12. Ocular surface squamous neoplasia in India: a study of 438 patients.
Kaliki S; Vempuluru VS; Ghose N; Gunda S; Vithalani NM; Sultana S; Ganguly A; Bejjanki KM; Jakati S; Mishra DK
Int Ophthalmol; 2022 Jun; 42(6):1915-1926. PubMed ID: 35094225
[TBL] [Abstract][Full Text] [Related]
13. Ocular surface squamous neoplasia: angiographic characteristics and response to subconjunctival/perilesional 5-fluorouracil injections.
Sun Y; Hua R
Drug Des Devel Ther; 2019; 13():1323-1334. PubMed ID: 31118569
[No Abstract] [Full Text] [Related]
14. Histopathological spectrum of ocular surface squamous neoplasia: A retrospective study of 776 lesions.
Mishra DK; Taneja S; Singh V; Veena U; Kaliki S
Indian J Pathol Microbiol; 2022; 65(1):3-7. PubMed ID: 35074957
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic correlation of ocular surface squamous neoplasia from a university hospital in North Taiwan 1994 to 2014.
Ma IH; Hu FR; Wang IJ; Chen WL; Hsu YJ; Chu HS; Yuan CT; Hou YC
J Formos Med Assoc; 2019 Apr; 118(4):776-782. PubMed ID: 30266199
[TBL] [Abstract][Full Text] [Related]
16. Ocular surface squamous neoplasia in HIV-infected patients: current perspectives.
Rathi SG; Ganguly Kapoor A; Kaliki S
HIV AIDS (Auckl); 2018; 10():33-45. PubMed ID: 29559813
[TBL] [Abstract][Full Text] [Related]
17. American Joint Committee on Cancer Staging and clinicopathological high-risk predictors of ocular surface squamous neoplasia: a study from a tertiary eye center in India.
Chauhan S; Sen S; Sharma A; Tandon R; Kashyap S; Pushker N; Vanathi M; Sharma N
Arch Pathol Lab Med; 2014 Nov; 138(11):1488-94. PubMed ID: 25357110
[TBL] [Abstract][Full Text] [Related]
18. Ocular Surface Squamous Neoplasia: A 12-Month Prospective Evaluation of Incidence in Waikato, New Zealand.
Hossain RR; Oh JA; McLintock C; Murphy C; McKelvie J
Vision (Basel); 2022 Aug; 6(3):. PubMed ID: 35997381
[TBL] [Abstract][Full Text] [Related]
19. Alterations of the bacterial ocular surface microbiome are found in both eyes of horses with unilateral ulcerative keratitis.
Julien ME; Shih JB; Correa Lopes B; Vallone LV; Suchodolski JS; Pilla R; Scott EM
PLoS One; 2023; 18(9):e0291028. PubMed ID: 37682941
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
